This study explores how inflammation and cholesterol levels predict cardiovascular events among 13,970 statin-intolerant patients in the CLEAR Outcomes trial. Findings suggest residual inflammatory risk may be a stronger predictor than residual cholesterol risk for future events. The research analyz

0 views • 17 slides

Hyperparathyroidism is characterized by overactive parathyroid glands leading to excessive secretion of parathyroid hormone and elevated blood calcium levels. This condition can cause symptoms like excessive urination, abdominal pain, weakness, and more. Primary hyperparathyroidism is often due to n

0 views • 20 slides

Liver complications in cystic fibrosis (CF) have gained importance due to CFTR modulators impacting liver health. This presentation by Dr. Zachary M. Sellers delves into new definitions for CF liver disease, CFF recommendations for screening, management, and treatment of hepatobiliary issues in CF.

0 views • 17 slides

Cardiovascular disease is a growing concern in individuals living with HIV, despite advancements in treatment. The REPRIEVE Trial sheds light on the importance of assessing cardiovascular risk and implementing primary prevention measures in this population. Dr. Grinspoon's financial disclosures and

0 views • 35 slides

The REPRIEVE trial focuses on developing a cardiovascular disease prevention strategy for individuals living with HIV. It addresses the increased risk of CVD in this population, even with good viral suppression. The study evaluates the use of pitavastatin, a statin with anti-inflammatory properties,

1 views • 33 slides

Explore the differences between pediatric and adult cardiovascular exams, highlighting key differences in disease patterns, examination approaches, and objectives. Learn about the importance of distinguishing between routine well-baby exams and evaluations of ill children, along with step-by-step gu

6 views • 24 slides

The CLEAR Outcomes Trial investigated the effects of bempedoic acid, an ATP citrate lyase inhibitor, on cardiovascular outcomes in primary prevention patients. Results showed a reduction in cardiovascular events with bempedoic acid, particularly in patients intolerant to statins. Baseline characteri

1 views • 13 slides

Understanding the impact of obesity stigma as a stressor throughout the lifecourse is essential, especially concerning pregnancy. The prevalence of pre-pregnancy overweight and obesity poses significant risks, leading to various maternal complications like gestational diabetes, cesarean delivery, an

0 views • 62 slides

Exploring the immediate and long-term effects of exercise on the cardiovascular system reveals the remarkable adaptations and responses the body undergoes. From short-term increases in heart rate and blood pressure to long-lasting changes in cardiac output, exercise plays a crucial role in enhancing

0 views • 13 slides

Pediatric patients undergoing cancer therapy face increased risks of oral health complications due to immunosuppression, including oral infections and tissue trauma. These can compromise treatment effectiveness, leading to higher morbidity, mortality, and healthcare costs. Strategies for assessing a

0 views • 12 slides

The impact of diet on the cardiovascular system is significant, with a high intake of LDL leading to clogged arteries and increased risk of Coronary Heart Disease. Regular exercise brings about positive changes in the cardiovascular system, enhancing heart function and oxygen delivery. Immediate ben

0 views • 7 slides

Hypertension, a common yet serious health issue, is explored in detail in this lecture. The etiology, risk factors, and complications of hypertension are discussed, along with the classification into primary, secondary, benign, and malignant hypertension. The lecture also covers causes of secondary

1 views • 13 slides

Strangles, also known as Equine Distemper, is an infectious disease affecting horses and equids. It is characterized by upper respiratory tract infection, lymph node abscesses, and various complications. Symptoms include nasal discharge, coughing, and swelling of lymph nodes. Prompt diagnosis and tr

3 views • 11 slides

Normal pregnancy induces significant physiologic changes in the cardiovascular system, which can impact women with pre-existing cardiac diseases. Understanding the New York Heart Association classification scheme is crucial for assessing symptomatology during pregnancy. Rheumatic Heart Disease, part

0 views • 12 slides

Proper documentation and coding of complications of medical and surgical care are essential for accurate classification and billing. Assigning codes based on the provider's documentation of the relationship between the condition and care is crucial. Complications must be clearly documented with a ca

1 views • 55 slides

Fractures can lead to a variety of complications, both locally and generally. General complications include shock, embolisms, crush syndrome, and more. Local complications can involve visceral, vascular, nerve injuries, compartment syndrome, infections, and more. Late complications may result in del

0 views • 29 slides

Hyperemesis gravidarum is a severe condition in pregnancy characterized by intractable nausea and vomiting, resulting in fluid and electrolyte imbalances, nutritional disturbances, and physical and psychological debilitation. The exact cause is unknown, but factors like hormonal changes, genetics, a

0 views • 22 slides

This report discusses the morphologic and physiologic connections in continuous blood pressure waveforms and their association with incident cardiovascular events. The study aims to assess if changes in arterial elasticity contribute to predicting CVD events and explores additional measures derived

0 views • 30 slides

Cardiovascular disease remains a significant contributor to maternal mortality in the UK, with maternal deaths from cardiac issues outnumbering those from other direct causes, except thrombosis. The prevalence of cardiovascular risk factors in pregnant women, combined with a lack of consideration fo

0 views • 22 slides

The data report examines the prevalence of cardiovascular diseases in adult End-Stage Renal Disease (ESRD) patients in 2016 by treatment modality and age. It includes information on various cardiovascular conditions such as atrial fibrillation, acute myocardial infarction, coronary artery disease, a

2 views • 25 slides

Complications of fractures can be classified as general, local early, and late complications. General complications include shock, embolisms, and fever while local complications involve injuries to nearby tissues and infections. Early local complications can lead to visceral, vascular, nerve injurie

0 views • 29 slides

This detailed presentation by Dr. Jasim Hasan covers the complications of fractures, including general and local complications, early and late complications, and specific issues such as shock, vascular injuries, nerve damage, and more. The information highlights the importance of recognizing and add

0 views • 29 slides

This informative content discusses the normal physiological changes of the cardiovascular system in pregnancy, symptoms and signs of cardiovascular disease, the impact of pregnancy on cardiovascular health, and the management of cardiovascular issues during pregnancy, labor, and the postpartum perio

0 views • 28 slides

This study aims to provide a quantitative analysis of patient-reported complications one year after mid-urethral slings in Sweden. The GynOp register covers all Swedish surgeries with a high coverage and patient response rate. The study, led by Stefan Zacharias and Eva Uustal, looks into complicatio

0 views • 17 slides

Explore the world of cardiovascular drugs, including antihypertensive, antianginal, heart failure, antiarrhythmic, diuretic, antithrombotic, and antihyperlipidemic medications. Dive into the mechanisms of action, clinical indications, and adverse effects of these drugs, gaining valuable insights int

0 views • 39 slides

In this detailed presentation, various aspects of medical risks associated with Electroconvulsive Therapy (ECT) are discussed, along with strategies to mitigate complications. Topics covered include the physiological effects of ECT on the cardiovascular, neurological, and endocrine systems, as well

0 views • 27 slides

Undesirable situations can arise during dental exodontia, including perioperative and postoperative complications. Perioperative complications may include crown fractures, soft tissue injuries, and failure to obtain anesthesia, while postoperative complications can involve trismus, hematoma, and wou

0 views • 48 slides

Women's health encompasses the screening, diagnosis, and management of diseases and conditions affecting physical and emotional well-being. Services are provided by a diverse team of healthcare professionals specializing in obstetrics, gynecology, surgery, and primary care. Cardiovascular disease is

0 views • 46 slides

Cardiovascular complications of thalassaemia can be categorized into iron overload-related issues such as myocyte failure and arrhythmias, and non-iron overload complications including pulmonary hypertension and atrial fibrillation. Cardiac iron accumulation poses a significant risk, leading to card

0 views • 36 slides

Cardiovascular effects of older glucose-lowering therapies and the history of cardiovascular outcome trials are discussed in this educational slide module. It outlines the timeline of treatment options from the discovery of insulin to the introduction of various medications. Evidence regarding the c

0 views • 29 slides

Individuals with type 2 diabetes have an increased risk of cardiovascular events compared to those without the condition. Research indicates that certain GLP-1 receptor agonists have shown promising results in reducing cardiovascular events in diabetic patients with specific HbA1c levels. However, t

0 views • 69 slides

The ATLAS-ACS 2 study investigated the efficacy and safety of rivaroxaban in ACS patients post-index event. The primary endpoints included cardiovascular death, MI, and stroke, with significant reductions seen with rivaroxaban compared to placebo. Stent thrombosis was also reduced with rivaroxaban t

0 views • 10 slides

GripTrack is a portable grip strength monitoring device designed to track cardiovascular and musculoskeletal health in the elderly population. It aims to provide an accurate early warning system by assessing grip strength, which can indicate cognitive decline, cardiovascular health, and frailty synd

0 views • 14 slides

This presentation discusses the significant cardiovascular effects of air pollution, particularly on vulnerable populations such as older adults, women, and Latinos. It highlights the environmental factors contributing to cardiovascular health disparities and emphasizes the nursing implications for

0 views • 13 slides

Explore the intricate workings of the cardiovascular system, encompassing the heart, blood vessels, and blood circulation. Learn the anatomy, physiology, and function of this vital system, including the roles of arteries, veins, capillaries, and red and blue blood. Understand how the cardiovascular

0 views • 23 slides

Understanding the prevalence and causes of cardiovascular diseases in patients with End-Stage Renal Disease (ESRD) is crucial for effective management. This report analyzes data from 2011-2013, focusing on the causes of death in ESRD patients, prevalence of cardiovascular diseases by treatment modal

0 views • 18 slides

Cardiologists in 2019 must address the significant cardiovascular risks associated with diabetes mellitus. Dr. Keith C. Ferdinand highlights the increased rates of heart disease, stroke, and heart failure in patients with diabetes. Despite advancements, cardiovascular risk management remains subopti

0 views • 10 slides

The Cardiovascular Disease Prevention Fellowship Programme by Health Innovation Network offers a comprehensive 7-month program for healthcare professionals to enhance their skills in cardiovascular disease prevention. The program includes clinical webinars, improvement collaborative sessions, and qu

0 views • 14 slides

The role of cardiovascular clinicians in managing cardiovascular risk in patients with type 2 diabetes is evolving, with a growing emphasis on collaboration with multidisciplinary teams. Recognizing the potential benefits of certain diabetes medications on cardiovascular outcomes, clinicians are urg

0 views • 25 slides

PCSK9 inhibitors are a novel class of medications that help lower LDL cholesterol levels, reducing the risk of cardiovascular events. This article covers their mechanism of action, patient groups benefiting from them, efficacy in LDL-C lowering, and safety considerations. Learn how PCSK9 inhibitors

0 views • 8 slides